Engineered tissues and organs have been grown with various degrees of success in labs for many years. Many of them have used a scaffolding approach where cells are seeded onto biodegradable supportive structures that provide the underlying architecture of the organ or tissue desired.
But scaffolds can be problematic — ultimately, they should degrade and disappear, but timing that decomposition to coincide with the maturation of the organ is tricky, and sometimes degradation byproducts can be toxic. Scaffolds also can interfere with the development of cell-to-cell connections, which are important for the formation of functional tissues.
Now, a research team led by Eben Alsberg, the Richard and Loan Hill Professor of Bioengineering and Orthopaedics at the University of Illinois at Chicago, has developed a process that enables 3D printing of biological tissues without scaffolds using “ink” made up of only stem cells. They report their results in the journal Materials Horizons.
“Our cell only printing platform allows for the 3D printing of cells without a classical scaffold support using a temporary hydrogel bead bath in which printing takes place,” Alsberg said.
Above: Bioprinting the letter “C” using a stem cell only ‘bioink’ into an alginate microbead supporting medium. Video courtesy of Oju Jeon and Eben Alsberg, University of Illinois at Chicago
The micron-scale hydrogel beads allow the nozzle of the 3D printer to move through it and deposit cells with minimal resistance to that nozzle movement or the ejection of the cells. The gel beads support the cells as they are printed and keeps them in place and preserves their shape.
Once the cells are printed into the hydrogel bead matrix, it is exposed to UV light, which cross-links the beads together, in effect freezing them in place. This lets the printed cells connect with each other, mature and grow within a stable structure. The media that bathes the cells flows easily through the cross-linked gel beads and can be changed out as needed to provide fresh nutrients and dispose of waste products made by the cells. The hydrogel beads can be removed through gentle agitation, or controlling their degradation, leaving the intact tissue behind.
“The hydrogel bead bath has unique properties which allow for both printing of the cell-only bioink in complex architectures, and subsequent temporary stabilization of these cell-only structures to allow for cell-cell junctions to form,” Alsberg said. “Using chemistry we can then regulate when the beads go away.”
The cells Alsberg’s team used are stem cells — those that can differentiate into a wide variety of other cell types. They used the stem cells to 3D print a cartilage ear and a rodent-sized “femur” in the hydrogel bead bath. The cells they printed were able to form stable, cell-cell connections through specialized proteins.
“For the first time, cell-only constructs can be printed in intricate forms that are made up of different cell types without a hydrogel carrier or traditional scaffold that can then be stabilized for a period of a day to weeks. We’ve demonstrated that individual cells and cell aggregates can be organized and assembled using this platform strategy to form larger functional tissues, which may be valuable for tissue engineering, drug screening and as models to study developmental biology,” Alsberg said.
Oju Jeon, Yu Bin Lee, Sang Jin Lee, and Derrick Wells of the bioengineering department at the University of Illinois at Chicago and Hyoen Jeong of Case Western Reserve University, are co-authors on the paper.
The Latest on: 3D printed tissues and organs
via Google News
The Latest on: 3D printed tissues and organs
- 3D Biological Printing Market Next Big Thing | Major Giants EnvisionTEC, Aspect Biosystems, 3Dynamic Systemson July 10, 2020 at 12:57 am
Latest released the research study on Global 3D Biological Printing Market, offers a detailed overview of the factors influencing the global business scope. 3D Biological Printing Market research ...
- Tel Aviv University, Bayer to test drugs on 3D-printed human heart tissueon July 9, 2020 at 7:15 am
The end goal is to “engineer whole human hearts for an even better toxicological screening process,” says TAU Laboratory for Tissue Engineering and Regenerative Medicine Professor Tal Dvir.
- Rice Researchers 3D Print with Lasers and Sugar to Build Complex Vascular Networkson July 7, 2020 at 5:34 am
A team of researchers from Rice University has uncovered a promising strategy to generate vascular networks, one of the most daunting structures in the human body. Using powdered sugar ...
- Engineers 3D-print sensors onto moving organson July 2, 2020 at 1:32 am
A new technique developed by University of Minnesota researchers allows 3D printing of hydrogel-based sensors directly on the surface of organs, such as lungs—even as they expand and contract ( ...
- Europe Healthcare 3D Printing Market Competitors Analysis, Overview, Growing Trends and Business Opportunities by 2024on July 1, 2020 at 1:38 pm
Selbyville, Delaware A research report on Europe Healthcare 3D Printing Market’ Added by Market Study Report, LLC, features a succinct analysis on the latest market trends. The report also includes ...
- Laser-welded sugar: Sweet way to 3D-print blood vesselson June 29, 2020 at 8:23 am
Rice University bioengineers have shown they can keep densely packed cells alive in lab-grown tissues by creating complex networks of branching blood vessels from templates of 3D-printed sugar.
- Bayer to test new drugs using human heart tissues 3D-printed at Tel Aviv Universityon June 29, 2020 at 7:28 am
Ramot at Tel Aviv University has signed a collaboration agreement with Bayer to develop and validate a platform for in vitro cardiotoxicity screening, using human heart tissues 3D-printed in Prof. Tal ...
- Bayer to test new drugs on 3D-printed heart tissue at Tel Aviv Universityon June 29, 2020 at 1:19 am
The new method of testing bypasses many tedious screening methods, making it faster, cheaper and more efficient.
- German Drugmaker Bayer To Test New Drugs With 3D-Printed Heart Tissues At TAUon June 28, 2020 at 6:51 am
As part of the agreement, Dvir's lab and Bayer will aim to test new cardiology medication for toxicity and efficacy.
- Israeli university, pharma giant Bayer to test drugs using 3D-printed human heart tissueson June 28, 2020 at 5:41 am
JERUSALEM, June 28 (Xinhua) -- Tel Aviv University (TAU) in central Israel announced Sunday that it has signed a collaboration agreement with German pharmaceutical giant Bayer to test new cardiac ...
via Bing News